Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy Male
Interventions
DRUG

TC-5214

Single dose, oral tablets

OTHER

Placebo comparator

Single dose, oral tablets

DRUG

Moxifloxacin

Single dose, oral encapsulated tablet

OTHER

Moxifloxacin placebo comparator

Single dose, oral encapsulated tablet

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY